|
|
Article: InnoCentive and Prize4Life Announce First Five Awards for Phase I of the Amyotrophic Lateral Sclerosis (ALS) Biomarker Challenge.(Company overview)
- Article from:
- Business Wire
- Article date:
- August 28, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Objective of Challenge to Find a Biomarker for Lou Gehrig's Disease
ANDOVER, Mass. -- InnoCentive, the global leader in open innovation sourcing, announced today that five Solvers have been chosen to receive prizes for the first phase of the Prize4Life ALS Biomarker Challenge. The five winners will receive $15,000 each for their proposals on how to identify an ALS biomarker. Three of the Solvers are from the U.S. and two from Europe.
Prize4Life is offering a total prize purse of $1 million dollars, through InnoCentive, for the successful identification of a novel biomarker for ALS/Lou Gehrig's disease. Finding a solution to the ALS Biomarker Challenge ...